Can I Buy TherapeuticsMD Inc Shares in India?

Yes, TherapeuticsMD Inc shares can be bought in India by opening an international trading account with Groww.

How to Buy TherapeuticsMD Inc Shares in India?

One can easily invest in TherapeuticsMD Inc shares from India by: Direct Investment - Opening an international trading account with Groww which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy TherapeuticsMD Inc shares. Indirect Investment - Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of TherapeuticsMD Inc.

What is the Share Price of TherapeuticsMD Inc?

The share price of TherapeuticsMD Inc is in Dollars and if you are investing from India, you can always check the INR valuation before investing. The current TherapeuticsMD Inc share price is $1.22 as of 13 Dec ‘24

What is the Market Cap of TherapeuticsMD Inc?

The TherapeuticsMD Inc market cap is $14.10M as of 13 Dec ‘24

What is the PE and PB ratio of TherapeuticsMD Inc?

The PE and PB ratio of TherapeuticsMD Inc is -4.3 and 0.5 as of 13 Dec ‘24

TherapeuticsMD Inc Share Price, TXMD Stock Price Quote Today

<img alt="TherapeuticsMD Inc" srcSet="https://viewlogo.s3.amazonaws.com/61437/conversions/597781-default.png 1x, https://viewlogo.s3.amazonaws.com/61437/conversions/597781-default.png 2x" src="https://viewlogo.s3.amazonaws.com/61437/conversions/597781-default.png" decoding="async" data-nimg="intrinsic" style="position:absolute;top:0;left:0;bottom:0;right:0;box-sizing:border-box;padding:0;border:none;margin:auto;display:block;width:0;height:0;min-width:100%;max-width:100%;min-height:100%;max-height:100%" class="companyLogo_companyImage__bT0On absolute-center uspp14Logo" loading="lazy"/>
TherapeuticsMD Inc Healthcare 
$1.22
-0.03(2.40%) 1D
1D
1W
1M
1Y
3Y
5Y
Performance
Open PricePrev. CloseVolumeAvg. Volume
$1.24$1.258,88920,654
FundamentalsMarket Cap$14.10M
P/B Ratio0.5
P/E Ratio-4.3
Enterprise Value$14.80M
Div. Yield0.00%
Book Value2.62
EPS(TTM)-0.32
ROENA
Understand Fundamentals
FUNDAMENTALS
It is financial information that is reported quarterly or annually.
Market Cap
Market cap or market capitalization is the total market value of all of a company's outstanding shares.
Div. Yield
The divided yield displayed as a percentage is the amount of money a company pays shareholders for owning a share of its stock divided by its current stock price
P/B Ratio
The price-to-book ratio is a company's current market price to its Book Value. Traditionally, any value under 1.0 is considered a good P/B value, indicating a potentially undervalued stock.
Book Value
The book value of a stock is theoretically the amount of money that would be paid to shareholders if the company was liquidated and paid off all of its liabilities.
P/E Ratio
The price-earnings ratio is a company's share price to the company's Earnings per Share. The ratio is used for evaluating companies and to find out whether they are overvalued or undervalued.
EPS(TTM)
Earnings per share (EPS) is a company's net profit divided by the number of common shares it has outstanding. EPS indicates how much money a company makes for each share of its stock, and is widely used metric to estimate corporate value
Enterprise Value
Enterprise Value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
ROE
Return on equity (ROE) is a measure of financial performance calculated by dividing net income by shareholder's equity
About the CompanyTherapeuticsMD, Inc. was established in the year 1907 in Utah and was concentrated on natural gas leases and oil. Currently, it is a women's health care company focused on creating and commercializing products that are targeted only at women. The company is now entirely focused on pursuing the regulatory approvals and pre-commercialization activities necessary for the commercialization of its highly advanced hormone therapies products. The company's clinical trials are designed to alleviate the symptoms of reduction in health risks that result from menopause and other related hormone deficiencies, which include hot flashes and vaginal discomfort. TherapeuticsMD is developing these hormone treatment medication candidates, which comprise estradiol and progesterone alone or in combination, with the goal of proving clinical effectiveness at lower dosages, allowing for a better side-effect profile than competing medicines. TherapeuticsMD is developing breakthrough hormone treatment pharmaceutical solutions using SYMBODATM technology to provide bio-identical hormones in a range of dose formulations and administration methods. Furthermore, the firm manufactures and distributes prescription prenatal vitamins, both branded and generic.;
OrganisationTherapeuticsMD Inc
Company Financials
*All values are in Million $
No Graph Data To Display
Quarterly
Yearly
See Details
Similar StocksCOMPANYMARKET PRICECLOSE PRICEMARKET CAP

Vaishnavi Tech Park, 3rd & 4th Floor
Sarjapur Main Road, Bellandur
Bengaluru – 560103
Contact Us
PRODUCTS
StocksFutures & OptionsMTFIPOMutual FundsNFOETFCreditBill Payments
GROWW
About UsPricingBlogMedia & PressCareersHelp and SupportTrust and Safety
QUICK LINKS
AMC Mutual FundsCalculatorsGlossaryOpen Demat AccountGroww DigestSitemapWeb Stories
ⓒ 2016-2024 Groww. All rights reserved, Built with ♥in India

Market Cap	$14.10M
P/B Ratio	0.5
P/E Ratio	-4.3
Enterprise Value	$14.80M

Open Price	Prev. Close	Volume	Avg. Volume
$1.24	$1.25	8,889	20,654